Comparison of the Effect of Helicobacter Pylori Eradication Before and After the Training of Gastroenterologists

NCT04984382 | Unknown

• 1 other identifier: 2021SDU-QILU-G004
• Study Type: interventional
• Target: 2,000
• Locations: 1 country
• Sites: 1

Brief Summary

The researchers recruited gastroenterologists. Physician subjects recruited Helicobacter pylori-positive patients before and after receiving standardized training on Helicobacter pylori eradication. There are no restrictions on treatment options and drugs during the trial. Compare the eradication rate, adverse reaction rate, and patient compliance before and after physician training.

Conditions

Helicobacter Pylori Infection

Keywords

Standardized training on Helicobacter pylori eradication; Gastroenterologist

Outcome Measures

Primary Outcomes (1)

• Eradication rate

  The eradication rate of before and after the gastroenterologists receiving standardized Helicobacter pylori eradication training

  1 year

Study Arms (2)

After receiving standardized training on Helicobacter pylori eradication

EXPERIMENTAL

After the gastroenterologists receive standardized training to eradicate Helicobacter pylori, they recruit Helicobacter pylori-positive patients for treatment.

Behavioral: Standardized training on Helicobacter pylori eradication treatment

Before receiving standardized training on Helicobacter pylori eradication

NO INTERVENTION

Gastroenterologists recruited patients with Helicobacter pylori positive for treatment before receiving standardized training on Helicobacter pylori eradication.

Interventions

Standardized training on Helicobacter pylori eradication treatment BEHAVIORAL

Standardized training on Helicobacter pylori eradication treatment

After receiving standardized training on Helicobacter pylori eradication

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Physician specialized in gastroenterology.
• Diagnosis and treatment conditions for H. pylori exist in the hospital where the gastroenterology doctor is located.
• (C13 urea breath test, C14 urea breath test, rapid urease test, stool H. pylori antigen test, histopathological test, H. pylori culture, any of the above)

You may not qualify if:

• Those who are unable or unwilling to provide informed consent.
• Patients with H. pylori have never been diagnosed and treated.

Sponsors & Collaborators

• Shandong University: lead

Study Sites (1)

Xiuli Zuo

Jinan, Shandong, 257000, China

RECRUITING

Study Officials

• Xiuli Zuo, MD,PhD

  Qilu Hospital of Shandong University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Xiuli Zuo, MD, PhD

CONTACT

86 15588818685; zuoxiuli@sdu.edu.cn

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: doctoral supervisor of Qilu Hospital gastroenterology department

Study Record Dates

• First Submitted: July 27, 2021
• First Posted: July 30, 2021
• Study Start: July 26, 2021
• Primary Completion: September 1, 2022
• Study Completion: September 1, 2022
• Last Updated: November 16, 2021

Record last verified: 2021-11

Locations

CN (1)